Cosmos HealthCOSM -10.91%29 Market Cap is $11.51 Mil as of Jun. 25, 2026. GuruFocus rates COSM with a GF Score™ of 29/100 and a GF Value™ of $0.36 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 122 Medical Distribution companies, Cosmos Health ranks worse than 81.97% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Cosmos Health's share price for the quarter that ended in Mar. 2026 was $0.3172. Cosmos Health's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 49.78 Mil. Therefore, Cosmos Health's market cap for the quarter that ended in Mar. 2026 was $15.79 Mil.
Cosmos Health's quarterly market cap
declined
from Sep. 2025 ($35.37 Mil) to Dec. 2025 ($20.45 Mil) and
declined
from Dec. 2025 ($20.45 Mil) to Mar. 2026 ($15.79 Mil).
Cosmos Health's annual market cap
declined
from Dec. 2023 ($22.41 Mil) to Dec. 2024 ($15.79 Mil) but then
increased
from Dec. 2024 ($15.79 Mil) to Dec. 2025 ($20.45 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Cosmos Health's Enterprise Value for Today is $28.38 Mil.
Cosmos Health (NAS:COSM) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Cosmos Health Market Cap Related Terms
Cosmos Health Market Cap Historical Data
* Premium members only.
The historical data trend for Cosmos Health's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Cosmos Health's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cosmos Health Market Cap vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Cosmos Health's Market Cap distribution charts can be found below:
* The bar in red indicates where Cosmos Health's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Cosmos Health's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cosmos Health (COSM) has a Market Cap of $11.51 Mil as of Jun. 25, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Cosmos Health and its competitors. According to the industry distribution chart, Cosmos Health ranks #100 out of 122 companies in the Medical Distribution industry, placing it in the top 82%.
Is Cosmos Health's Market Cap too high?
Cosmos Health's current Market Cap is $11.51 Mil. The Medical Distribution industry median Market Cap is 139.40. Cosmos Health's value of $11.51 Mil is 91.7% below this industry median. Based on the distribution chart, Cosmos Health ranks #100 out of 122 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Cosmos Health has a GF Score™ of 29/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cosmos Health's Market Cap compare to HKPD and VNOV?
According to the Medical Distribution industry distribution chart, Cosmos Health ranks #100 out of 122 companies for Market Cap. This places Cosmos Health in the lower half of its industry. The industry median Market Cap is 139.40. Cosmos Health's value of $11.51 Mil is 91.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Distribution company?
The median Market Cap among Medical Distribution companies is 139.40, based on 122 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cosmos Health's current Market Cap of $11.51 Mil is 91.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Cosmos Health and its competitors. For the Medical Distribution industry, the median Market Cap is 139.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cosmos Health's current Market Cap is $11.51 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cosmos Health stock overvalued right now?
Based on GuruFocus' analysis, Cosmos Health (COSM) is currently considered Possible Value Trap. The stock's GF Value™ is $0.36, compared to a current price of $0.19 — trading 48.5% below its estimated fair value. The current Market Cap is $11.51 Mil and 91.7% below the Medical Distribution industry median of 139.40. Cosmos Health's overall GF Score™ is 29/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Cosmos Health (COSM), the current Market Cap is $11.51 Mil as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cosmos Health (COSM) Overvalued in 2026?
Based on GuruFocus' analysis, Cosmos Health stock appears to be undervalued.
The current stock price of $0.19 is trading 48.5% below its estimated GF Value™ of $0.36.
GuruFocus considers Cosmos Health to be Possible Value Trap.
Key valuation signals for COSM:
Market Cap: $11.51 Mil
GF Value™: $0.36 vs. price of $0.19 (48.5% below fair value)
Industry Position: 91.7% below the Medical Distribution median (#100 of 122)
No single metric tells the full story. See the COSM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.
29GF Score
Get the complete analysis for COSM
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
COSM has been successfully added to your 
